Strides Pharma schedules investor conference for Q1 FY26 earnings

Strides Pharma Science Limited announced an upcoming analyst and institutional investor meeting to be held on September 23, 2025, starting at 10:00 hrs. The company will participate in an investor conference organized by DAM Capital, which will be an in-person, one-on-one event in Mumbai.

The primary focus of these meetings will be the earnings deck of Q1 FY26. This document, previously uploaded on stock exchanges and the company's website on July 29, 2025, will serve as the discussion material. The intimation for this meeting was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Manjula Ramamurthy, company secretary & compliance officer, digitally signed the announcement on September 17, 2025.